Sagimet Biosciences Inc.
Recent Filings
All 219 filings →| Form | Description | Date |
|---|---|---|
| S-8 | FORM S-8 | Mar 11, 2026 |
| S-8 | FORM S-8 | Mar 11, 2026 |
| 8-K | FORM 8-K | Mar 11, 2026 |
| 10-K | 10-K | Mar 11, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 20, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 20, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 20, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 20, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 12, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 12, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Kemble George | Executive Chairman | Sale | 37,688 @ $7.69 | 81,005 | Nov 20, 2025 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Award / Grant | 9,855 | 193,581 | Nov 4, 2025 |
| Happel David | President & CEO | Sale | 65,478 @ $9.13 | 689,722 | Jul 21, 2025 |
| Martins Eduardo Bruno | Chief Medical Officer | Sale | 8,277 @ $9.13 | 106,936 | Jul 21, 2025 |
| Rozek Elizabeth | General Counsel and CCO | Sale | 10,780 @ $9.13 | 183,726 | Jul 21, 2025 |
| Martins Eduardo Bruno | Chief Medical Officer | Award / Grant | 34,000 | 115,213 | Feb 6, 2025 |
| Happel David | President & CEO | Award / Grant | 116,000 | 755,200 | Feb 6, 2025 |
| Rozek Elizabeth | General Counsel and CCO | Award / Grant | 34,000 | 194,506 | Feb 6, 2025 |
| Chauche Thierry | Chief Financial Officer | Award / Grant | 17,000 | 17,000 | Feb 6, 2025 |
| Kemble George | Executive Chairman | Sale | 23,625 @ $3.17 | 118,693 | Jul 23, 2024 |